Does BORTEZOMIB Cause Plasma cell myeloma refractory? 618 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 618 reports of Plasma cell myeloma refractory have been filed in association with BORTEZOMIB (bortezomib). This represents 1.3% of all adverse event reports for BORTEZOMIB.
618
Reports of Plasma cell myeloma refractory with BORTEZOMIB
1.3%
of all BORTEZOMIB reports
39
Deaths
45
Hospitalizations
How Dangerous Is Plasma cell myeloma refractory From BORTEZOMIB?
Of the 618 reports, 39 (6.3%) resulted in death, 45 (7.3%) required hospitalization, and 13 (2.1%) were considered life-threatening.
Is Plasma cell myeloma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BORTEZOMIB. However, 618 reports have been filed with the FAERS database.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Plasma cell myeloma refractory?
DEXAMETHASONE (513)
LENALIDOMIDE (489)
DARATUMUMAB (404)
CARFILZOMIB (386)
POMALIDOMIDE (280)
CYCLOPHOSPHAMIDE (237)
IXAZOMIB (132)
DOXORUBICIN (115)
ETOPOSIDE (90)
THALIDOMIDE (89)
Which BORTEZOMIB Alternatives Have Lower Plasma cell myeloma refractory Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX